project id: TCGA-KIRP; case submitter id: TCGA-IA-A40U; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.12; rna integrity number: 8.8; age at index: 56; days to birth: -20463; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 20463; ajcc clinical m: MX; ajcc clinical n: N0; ajcc clinical stage: Stage III; ajcc clinical t: T3b; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 511.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 201; days to sample procurement: 0; initial weight: 570.0; portion submitter id: TCGA-IA-A40U-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;